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Macrophages act as the primary effector cells during
Leishmania infection through production of reactive
oxygen species (ROS) and interleukin-1b (IL-1b).
However, how macrophage-killing mechanisms are
activated during Leishmania-macrophage interac-
tions is poorly understood. Here, we report that the
macrophage response against Leishmania infantum
in vivo is characterized by an M2b-like phenotype
and C-type lectin receptors (CLRs) signature com-
posed of Dectin-1, mannose receptor (MR), and the
DC-SIGN homolog SIGNR3 expression. Dectin-1
and MR were crucial for the microbicidal response
as indicated by the fact that they activated Syk-
p47phox and arachidonic acid (AA)-NADPH oxidase
signaling pathways, respectively, needed for ROS
production and also triggered Syk-coupled signaling
for caspase-1-induced IL-1b secretion. In contrast,
SIGNR3 has divergent functions during Leishmania
infantum pathogenesis; this CLR favored parasite re-
silience through inhibition of the LTB4-IL-1b axis.
These pathways also operated during infection of
primary human macrophages. Therefore, our study
promotes CLRs as potential targets for treatment,
diagnosis, and prevention of visceral leishmaniasis.
INTRODUCTION
Leishmaniasis is one of the world’s most neglected diseases,
affecting about 12 million people worldwide, with a range of
1.5 to 2 million new cases yearly (World Health Organization,
2010). Leishmania species are intracellular protozoan parasites
that cause multiple diseases ranging from nonlethal cutaneous
leishmaniasis to deadly visceral disease (VL). Macrophages are1038 Immunity 38, 1038–1049, May 23, 2013 ª2013 Elsevier Inc.the primary replication sites for this parasite and the major
effector cells to combat against it (Van Assche et al., 2011).
Among the antimicrobial strategies in macrophages is the pro-
duction of reactive oxygen species (ROS) and interleukin-1b
(IL-1b) (Liese et al., 2008). Indeed, ROS production through
NADPH oxidase affects Leishmania survival in vitro, and its
inhibition prevents murine and human macrophages from killing
Leishmania donovani (L.d.), correlating with the susceptibility to
VL displayed by the respiratory burst-deficient (Cybb/ encod-
ing gp91phox) mice (Liese et al., 2008; Murray and Nathan,
1999). Likewise, IL-1b controls the immune manifestations in
leishmaniasis and influences the clinical course of the disease.
Its production and activation require two distinct signals. Signal
1 is triggered by microbial stimulus through pattern recognition
receptors (PRRs) and results in intracellular stores of pro-IL-1b;
signal 2 assembles a multiprotein complex called the inflamma-
some, leading to enzymatic cleavage by caspase-1 of the pro-IL-
1b and release of its active form (Martinon et al., 2009). The
mechanisms upstream of the inflammasome activation respon-
sible for the IL-1b response against Leishmania are unknown.
The regulation of these effector molecules is likely to involve
signaling pathways activated by the interaction between Leish-
mania and macrophages. Indeed, several macrophage surface
receptors participate in the recognition and internalization of
Leishmania (Akilov et al., 2007; Liese et al., 2008; Stafford
et al., 2002). However, only the Toll-like receptors (TLRs) and
C-type lectin receptors (CLRs) participate in the signaling path-
ways involved in macrophage-killing mechanisms. Among
CLRs, ideal candidates because of their ligand binding patterns,
signal transduction capabilities, and proven biological roles in
pathogenic contexts are (1) mannose receptor (MR), (2) the
murine dendritic cell-specific intercellular adhesion molecule-
3-grabbing nonintegrin (DC-SIGN) homolog, specific intercel-
lular adhesion molecule-3-grabbing nonintegrin receptor 3
(SIGNR3), and (3) Dectin-1 (Osorio and Reis e Sousa, 2011).
The MR is a type I transmembrane receptor with a N-terminal
cysteine-rich domain, a single fibronectin domain, eight carbo-
hydrate recognition domains (CRDs), and a short cytoplasmic
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recognizes terminal glycosylated motifs, such as D-mannose,
L-fucose, and N-acetyl-D-glucosamine. Although the impor-
tance of MR to the Leishmania-macrophage interaction was
demonstrated in vitro, its in vivo role remains questionable given
that MR-deficient mice display no defects in cytokine produc-
tion, infection rates, or clinical scores during Leishmania infec-
tion (Akilov et al., 2007; Wilson and Pearson, 1988). Unlike MR,
SIGNR3 is a type II transmembrane receptor containing a CRD
in its C terminus capable of recognizing mannose residues in
pathogens and signaling through a hemi-immunoreceptor tyro-
sine-based activation motif (hemITAM)-Syk pathway (Tanne
et al., 2009). Its human counterpart, DC-SIGN, recognizes
mannose residues during the Leishmania interaction with den-
dritic cells (Caparro´s et al., 2005). Like SIGNR3, Dectin-1 is a
type II transmembrane receptor composed of an extracellular
CRD and an intracellular domain with an ITAM motif capable to
recruit Syk family kinases and transduce signals (Osorio and
Reis e Sousa, 2011). This CLR is themajor macrophage receptor
for b-1,3 glucans, which could serve as recognition motifs
because they usually branch off from the major cell surface gly-
coconjugate, i.e., lipophosphoglycan (LPG), of all Leishmania
parasites (Brown et al., 2003; Coelho-Finamore et al., 2011).
The b-glucan-induced inflammasome activation is dependent
on the Dectin-1-Syk signaling pathway (Cheng et al., 2011;
Hise et al., 2009). Moreover, Dectin-1 induces ROS production
in response to b-glucan particles in a Syk-dependent manner
(Underhill et al., 2005), highlighting this Syk-coupled receptor
as an activator of inflammatory responses against pathogens
(Cheng et al., 2011; Hise et al., 2009). Unlike MR, however,
no direct involvement of SIGNR3 or Dectin-1 in Leishmania
recognition and microbicidal-associated functions has been
reported yet.
A recent study implicated the state of macrophage polariza-
tion in the susceptibility of mice to cutaneous leishmaniasis
(Ho¨lscher et al., 2006). Two programs broadly classify polarized
macrophages: classical (M1) and alternative (M2). The M1 pro-
gram arises from type 1 inflammatory conditions (e.g., IFN-g)
and pathogenic challenge. M1 macrophages are characterized
by elevated levels of complement and Fcg receptors, high pro-
duction of proinflammatory signals and microbicidal molecules,
and resistance against intracellular pathogens, among others.
The M2 program is a diverse response to type 2 immune signals
such as IL-4 (M2a); immune complexes, TLR agonists, or IL-1
receptors (M2b); and immunosuppresants like IL-10 (M2c). M2
macrophage activity includes the suppression of inflammation
and tissue remodeling/repair, among others (Mantovani et al.,
2004; Martinez et al., 2008). M2 macrophage subsets in general
are characterized by abundant amounts of CLRs.
In the present study, we examined macrophage polarization in
the context of VL. The macrophage response of B6 mice against
Leishmania infantum (L.i.) was characterized by a M2b-like
phenotype accompanied by CLR signature composed of
Dectin-1, MR, and SIGNR3. Both Syk-coupled Dectin-1 and
MR were crucial for the macrophage microbicidal response as
shown by the fact that they activated signaling pathways for
ROS production and IL-1b secretion. By contrast, SIGNR3
expression in macrophages favored parasite resilience through
inhibition of LTB4 production resulting in decreased IL-1brelease. Finally, we demonstrated that human homologs for
each CLR display similar contributions to the Leishmania-
macrophage interaction, highlighting the relevant but divergent
role for CLRs to Leishmania pathogenesis.
RESULTS
Macrophages Respond to L.i. Challenge with Activation
of a M2b-like Program and CLR Signature
Microbicidal activities are tightly dependent of macrophage
polarization state. Based on established criteria to distinguish
between M1 and M2macrophages, we assessed the phenotype
of the macrophage response to L.i. infection in the B6 genetic
background. Upon parasitic challenge, macrophages displayed
a downregulation of mRNA levels of M1 markers like Fcg recep-
tors (Fcgr3 [encoding CD16], Fcgr2b [encoding CD32], and
Fcgr1 [encoding CD64]) and the inducible nitric oxide synthase
(Nos2), which was mirrored by the upregulation of bona fide
M2 markers Chi3l3 (encoding YM1), Arg1 (encoding Arginase1),
and Cd36 (encoding CD36) (Figure 1A). This finding was further
supported by the reciprocal reduction of CD16 and CD32 and
increase of CD36 and YM1 at the protein level (Figure 1B). It is
well known that CLRs are expressed in leukocytes of themyeloid
lineage, and within the context of macrophage polarization,
CLRs preferentially act as markers of M2 macrophages (Manto-
vani et al., 2004). We monitored the abundance of CLRs in mac-
rophages during L.i. infection. We observed unaffected mRNA
amounts for the M1markerClec4e (encoding Mincle) (Figure 1C)
or the M2 marker Clec10a (encoding macrophage galactose
lectin) (data not shown). However, L.i. infection strongly upregu-
lated Clec7a (encoding Dectin-1), Mrc1 (encoding MR), and
Cd209d (encoding SIGNR3) mRNA and protein (Figures 1C
and 1D). Key proinflammatory cytokines such as TNF-a, IL-1b,
and IL-6 were also induced in macrophages during L.i. infection
(Figures 1E and 1F). However, this proinflammatory signature in
macrophages was accompanied by production of anti-inflam-
matory IL-10, IL-1 receptor antagonist (IL-1rn), and TGF-b1 in
high amounts (Figures 1E and 1F). Only M2b macrophages are
characterized by simultaneous production of proinflammatory
cytokines and IL-10, together with CCL1 a bona fide marker of
M2b polarization (Mantovani et al., 2004). Accordingly, we
observed a significant increase of CCL1 and CCL17 (another
anti-inflammatory chemokine) mRNA and protein in macro-
phages from B6 mice in response to L.i. (Figures 1E and 1F).
These observations were confirmed in macrophages freshly
isolated from mice 14 or 60 days after infection (Figures S1A
and S1B available online). Furthermore, we obtained similar
observations in the macrophage response against L.d. infection,
suggesting that activation of M2b-like macrophages along with
its CLR signature is not species specific (Figure S1C). Taken
together, these results indicated that L.i. infection induces a
macrophage M2b-like phenotype characterized by a CLR signa-
ture composed of Dectin-1, MR, and SIGNR3.
CLRs Have Distinct Contributions to the Macrophage
Response and Outcome of Leishmania Infection
To explore whether the timely expression of Dectin-1, MR, and
SIGNR3 has any functional consequence to L.i. infection, we
assessed the host response through the use of mouse modelsImmunity 38, 1038–1049, May 23, 2013 ª2013 Elsevier Inc. 1039
Figure 1. M2b-like Macrophages Express Dectin-1, MR, and SIGNR3 during L.i. Infection in B6 Genetic Background
(A, C, and E) qRT-PCRanalysis of biological markers forM1 andM2 polarization programs in peritonealmacrophages fromB6mice in response to L.i. stimulation.
(B and D) Cell-surface protein levels for the indicated polarization markers as quantified by flow cytometry after challenge with L.i.
(F) Protein levels for the indicated genes as quantified by ELISA in the supernatant of peritoneal macrophages from B6 mice in response to L.i. stimulation.
For qRT-PCR analysis, ELISA quantification, and flow cytometry geomean, infection with L.i. is denoted by black bars (+L.i.) and the mock control by white bars
(L.i.). For flow cytometry overlay profiles, macrophages challenged with L.i. are denoted by unfilled black overlay (+L.i.) and the mock control by filled gray
overlay (L.i.) and geomean fluorescence values were noted. Results correspond to mean ± SEM of triplicates. Data are representative of three independent
experiments. *p < 0.05, **p < 0.001 compared to the mock control (L.i.). The mRNA levels were represented in fold induction relative to the mRNA levels
observed for the mock control samples. See also Figure S1 and Table S2.
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mental Procedures and illustrated in Figure S2A, we generated
MR-conditionally-deficient (Mrc1/) mice in which the Mrc11040 Immunity 38, 1038–1049, May 23, 2013 ª2013 Elsevier Inc.gene was selectively disrupted in myeloid-derived cells,
including macrophages. Recently, this conditional gene-target-
ing strategy was successfully validated for the myeloid-specific
Figure 2. Dectin-1, MR, and SIGNR3 Have Distinct Contributions to the L.i. Infection Outcome and the Functional Macrophage Response
(A–C) Clec7a/,Mrc1/, and Cd209d /mouse models (black) and their corresponding WT counterparts (gray, +/+), were infected (i.p.) with 503 106 L.i. for
14 days. The number of mice is listed in (B). For the adoptive transfer experiment (C), each CLR-deficient mouse was injected i.p. with 6 3 106 macrophages
harvested from their respectiveWT counterpart 10 hr before L.i. inoculation (AT) (n = 6mice per group). Quantification of L.i. parasite number in the spleen (A, C) or
in the blood (B, C) for each CLR-deficient mouse model was measured by qRT-PCR analysis. The number of mice that tested positive for L.i. in the blood after
2 weeks of infection was determined by qRT-PCR analysis (B). Data are represented as mean ± SEM; *p < 0.05 compared to WT mice.
(D–F) Proliferation (D), binding and phagocytosis (E), and ROS induction (F) of L.i.-luciferase were measured in peritoneal macrophages from each CLR-deficient
mouse model, compared to its corresponding WT (+/+) counterpart. For indicated measurements, pretreatment with Bay was performed before the challenge
with L.i. Data are expressed as fold induction relative to the luminescence or chemiluminescence observed for WT without treatment. Results correspond to
mean ± SEM of triplicates and are representative of at least three independent experiments. *p < 0.05, **p < 0.001 compared to untreated WT and #p < 0.05,
##p < 0.001 compared to untreated CLR-deleted mice.
See also Figure S2.
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demonstrate its role in the elimination of C. albicans (Gale`s
et al., 2010). As for SIGNR3, given that its expression is confined
to myeloid mononuclear cells including different macrophage
subsets (Nagaoka et al., 2010), we used Cd209d (encodingSIGNR3)-deficient mice that were instrumental to demonstrate
its role in host defense against M. tuberculosis (Tanne et al.,
2009). As depicted in Figures 2A and 2B, targeted deficiencies
for Dectin-1 or MR in the myeloid compartment led to a higher
parasite burden in the blood and spleen. Surprisingly, however,Immunity 38, 1038–1049, May 23, 2013 ª2013 Elsevier Inc. 1041
Figure 3. Dectin-1-Syk-p47phox and MR-AA-NADPH Oxidase
Signaling Pathways Induce the Respiratory Burst in Response to
Leishmania
(A) Phosphorylated p47phox immunoblot after L.i. infection (3 hr) in peritoneal
macrophages from each CLR-deficient mouse model (/) and its corre-
sponding WT counterpart (+/+). ‘‘C’’ denotes nontreated control samples.
Pretreatment with Bay was performed before the challenge with L.i. Band in-
tensity was quantified with Image J software and was represented as the ratio
between the band intensities of phosphorylated p47phox and of p47phox.
(B and C) AA release (B) and ROS production (C) by peritoneal macrophages
from B6 mice treated or not with MAFP in response to L.i. challenge. Data are
expressed as fold induction relative to untreated macrophages.
(D) AA release was measured for peritoneal macrophages from each CLR-
deficient mouse model in response to L.i. challenge and expressed as the
percentage of AA released relative to that of WT (+/+) macrophages (set
arbitrarily at 0%).
Results correspond to mean ± SEM of triplicates and are representative
of three independent experiments. *p < 0.05, **p < 0.001 compared to un-
treated WT.
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parasitemia in comparison toWT littermates (Figures 2A and 2B).
To investigate whether CLR expression in macrophages had
any relevant functional consequence to the observed in vivo
outcomes, we performed adoptive transfers of corresponding
WT macrophages into each CLR-deficient mouse model. We
found that WT macrophages significantly reduced the blood
and spleen parasitic burden in both Clec7a/ and Mrc1/
mice (Figure 2C). For Cd209d-deficient mice, however, the
adoptive transfer of the corresponding WT macrophages did
not significantly alter the infection outcome.
To further characterize the role of theseCLRs inmacrophages,
we dissected the macrophage response to L.i. challenge in vitro.
Similar to the parasitic susceptibility observed in the corre-
sponding mouse model, peritoneal macrophages lacking either
Dectin-1 or MR became permissive to L.i. proliferation com-
pared to the WT counterparts. By contrast, those lacking
SIGNR3 were nonpermissive (Figure 2D). In terms of recognition
and phagocytosis of L.i., deficiencies for each CLR resulted in a
small but significant diminished capacity for macrophages to
interact with this pathogen (Figure 2E). Supporting these
findings, we also observed that, with the exception of SIGNR3,
Dectin-1 and MR are involved in the phagocytosis of L.d. by
macrophages (Figure S2B). Moreover, ROS production in
response to L.i. and L.d. challenge became substantially
affected in macrophages lacking either Dectin-1 or MR, whereas
that of macrophages lacking SIGNR3 remained intact (Figures
2F and S2B). Altogether, these data demonstrated that Dectin-1
and MR favored the host response because they were involved
in the microbicidal macrophage response against L.i., whereas
the expression of SIGNR3 seemed to be redundant in vivo but
had an apparent negative role in the macrophage control of
this parasite’s proliferation.
Dectin-1-Syk-p47phox and MR-AA-NADPH Oxidase
Signaling Induce the Respiratory Burst in Response
to L.i.
Deficiencies for Dectin-1 or MR rendered peritoneal macro-
phages permissive to L.i. proliferation and less capable of
producing ROS (Figure 2). Because ROS are essential
Leishmania-killing components, we investigated the signaling
pathways involved in their production. Recently, Dectin-1 was
reported to induce ROS production in response to b-glucan
particles through a signaling cascade requiring Syk, a protein
kinase that regulates NADPH oxidase activity in macrophages
(Underhill et al., 2005). To evaluate whether the release of ROS
in response to L.i. is dependent on Syk-coupled signaling, we
measured ROS production in macrophages pretreated with the
selective Syk inhibitor Bay 61-3606 (Bay) (Yamamoto et al.,
2003). Not only did the inhibition of Syk-coupled signaling
abolish ROS production in themacrophage response to L.i. chal-
lenge (Figure 2F), but it also led to uncontrolled L.i. proliferation in
all macrophages (Figure 2D). Next, we evaluated the amount of
phosphorylation of p47phox, a cytosolic subunit of the NADPH
oxidase complex whose activation is essential to this pro-
cess. Immunoblot analysis revealed that after L.i. infection, the
amount of phosphorylated p47phox was significantly decreased
in Dectin-1-deficient macrophages, whereas macrophages
deficient for MR or SIGNR3 were unaffected (Figure 3A).1042 Immunity 38, 1038–1049, May 23, 2013 ª2013 Elsevier Inc.Furthermore, the pretreatment of all macrophages with Bay in-
hibited p47phox phosphorylation, demonstrating that Syk-
coupled signaling is essential in the activation of p47phox in
response to L.i. (Figure 3A).
We next investigated the assembly of cytosolic phox subunits
of NADPH oxidase, another crucial event for ROS production.
This stage is under the control of arachidonic acid (AA) that,
once generated from membrane phospholipids cleavage by
cPLA2 enzyme, promotes the interaction between the cytosolic
p47phox and p67phox and the membrane-bound flavocyto-
chrome-b (Dana et al., 1998). Pretreatment of macrophages
with MAFP, an irreversible inhibitor of cPLA2 enzymatic activity,
inhibited AA release and ROS production (Figures 3B and 3C).
Furthermore, although L.i. infection resulted in the induction of
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failed to do so in macrophages lacking MR, thus establishing a
direct link between the MR and AA signaling pathways
(Figure 3D).
Taken together, these results demonstrated that both Dectin-
1-Syk-p47phox phosphorylation and MR-AA-NADPH oxidase
membrane translocation axis were essential in the induction of
the respiratory burst in response to L.i.
Dectin-1 and MR Partly Induce IL-1b via a Caspase-1-
Dependent Inflammasome in Response to L.i.
Our data suggest that Dectin-1, MR, and SIGNR3 contribute
differently to the overall macrophage response after challenge
to L.i. In order to verify whether this holds true for the cytokine
response, we measured the induction of IL-1b and TNF-a secre-
tion in peritoneal macrophages upon L.i. infection from mice
lacking each CLR. Although the release of both cytokines was
diminished in the absence of Dectin-1 or MR, SIGNR3-deficient
macrophages displayed elevated and unchanged amounts of
IL-1b and TNF-a, respectively (Figures 4A and S3A). Given that
IL-1b plays an important role in antileishmanial host defense
and that the mechanism by which macrophages regulate its pro-
duction after Leishmania recognition is unknown, we investi-
gated whether the deficiency of IL-1b secretion was due to a
defective production step. As shown in Figure 4B, L.i.-induced
Il1b mRNA production was reduced in Dectin-1- and
MR-deficient macrophages. However, SIGNR3-deficient mac-
rophages displayed elevated amounts of Il1b mRNA upon L.i.
challenge (Figure 4B). Next, we examined whether these CLRs
were also required for the processing of pro-IL-1b into its mature
form. With regards to Dectin-1, a role for the canonical caspase-
1-dependent NLRP3 inflammasome was shown in the process-
ing of C. albicans-induced pro-IL-1b (Gross et al., 2009; Osorio
and Reis e Sousa, 2011). For this reason, we evaluated IL-1b
secretion in the presence of Z-VAD-FMK (z-vad), an inhibitor of
proteases belonging to the caspase family. In Figure 4C, the
use of z-vad revealed that IL-1b maturation induced by L.i.
challenge was dependent on caspase activation because its
secretion was abrogated in all macrophages. To further explore
whether caspase-1-dependent inflammasome was activated in
L.i.-stimulated macrophages, we determined the activation
status of this enzyme by monitoring the appearance of the p20
cleavage product (Figure 4D). The active subunit of p20
increased in WT macrophages challenged with L.i., whereas
a partial decrease was observed in macrophages from
Clec7a- and Mrc1-deficient mice. Conversely, the active p20
subunit increased in SIGNR3-deficient macrophages, corre-
lating with increased IL-1b secretion.
Considering the implications of identifying Dectin-1 andMR as
extracellular sensors for Leishmania PAMPs (pathogen-associ-
ated molecular patterns) that control pro-IL-1b processing by
the activation of caspase-1-dependent inflammasome, we
next evaluated the upstream mechanisms associated with the
secretion of this important cytokine. We first assessed whether
parasite internalization was a prerequisite for IL-1b secretion.
Treatment of peritoneal macrophages isolated from the different
mouse strains with Latrunculin A, which interferes with the inter-
nalization but not the binding to Leishmania, completely inhibited
IL-1b secretion upon challenge with L.i. (Figure 4E). We thenaskedwhether signaling through Sykwas involved in the produc-
tion of IL-1b. Indeed, alongwith TLR2 andDectin-1, this signaling
molecule was shown to be required for the priming step of the
NLRP3 inflammasome in response to C. albicans (Gross et al.,
2009; Osorio and Reis e Sousa, 2011). We pretreated peritoneal
macrophages isolated from the different mouse strains with the
Bay inhibitor before L.i. infection and noticed that it abolished
IL-1b secretion (Figure 4E). Finally, we examined whether ROS
production occurred upstream of inflammasome activation
responsible for IL-1b induction by Leishmania. ROS production
might act as a common cellular signal upstream of the NLRP3
inflammasome complex, as indicated by the fact that ROS
scavengers and NAPDH oxidase inhibitors block its activation
(Gross et al., 2009). In line with those findings, the antioxidant
N-acetyl cysteine (NAC) partly suppressed Leishmania-induced
IL-1b secretion by all macrophages (Figure 4E). Therefore, these
results showed that in response to L.i., the caspase-1-induced
IL-1b release is activated by Dectin-1 and MR and suggested
a negative role for SIGNR3 in this process.
SIGNR3 Promotes Parasite Resilience in Macrophages
by Downregulating IL-1b via LTA4H
Although our efforts to dissect the intracellular signals leading to
microbicidal activity shed light on the contribution by Dectin-1
and MR, they provided thus far inconclusive evidence for the
role of the signals triggered by SIGNR3. In vitro characterization
suggested that signals downstream of SIGNR3 shift macro-
phages toward a permissive state, best reflected by the lower
rate of parasitic proliferation in SIGNR3-deficient macrophages
(Figure 2D). In addition, we also observed that in the absence
of SIGNR3, macrophages produced elevated amounts of IL-1b
both at the mRNA and protein levels (Figures 4A and 4B),
accompanied by high levels of caspase-1 activation (Figure 4D),
suggesting that SIGNR3modulates inflammasome activation for
the parasite’s benefit.
Recently, L.d.was shown to induce the synthesis of the proin-
flammatory leukotriene B4 (LTB4), an eicosanoid mediator
known to be essential for the control of VL (Serezani et al.,
2006). Because LTB4 is equally necessary for the inflammasome
activation, and hence for optimal IL-1b production (Amaral et al.,
2012), we evaluated the generation of LTB4 by the CLR-deficient
macrophages upon L.i. challenge. In contrast to reduced LTB4
production in MR-deficient macrophages, LTB4 production by
SIGNR3-deficient macrophages was elevated compared to
that of WT counterparts (Figure 4F). We next investigated the
expression of factors upstream of LTB4 production. LTB4 is
derived from the metabolism of the cell membrane fatty acid
AA via the enzymatic actions of 5-lipoxygenase (ALOX5) in
concert with leukotriene A4 hydrolase (LTA4H) (Serhan, 2005).
Consistent with the increase of LTB4 production in SIGNR3-
deficient macrophages, L.i. infection increased Lta4h transcripts
without affectingAlox5mRNA (Figure 4G). Conversely, L.i. signif-
icantly reduced Lta4h mRNA and increased Alox5 mRNA in
MR-deficient macrophages, correlating with the reduced LTB4
secretion (Figure 4G).
The modulation of enzyme expression involved in the synthe-
sis of eicosanoid mediators by CLR prompted us to examine the
production of lipoxin A4 (LXA4), an anti-inflammatory factor
known to both abrogate the IL-1b-mediated inflammatoryImmunity 38, 1038–1049, May 23, 2013 ª2013 Elsevier Inc. 1043
Figure 4. The Inflammatory Cytokine Induction in Response to L.i. Is Controlled Differently by CLRs
(A and B) IL-1b protein (A) and mRNA (B) levels in peritoneal macrophages from each CLR-deficient mouse model (black bar) and its corresponding WT
counterpart (gray bar, +/+) after L.i. challenge and measured by ELISA and qRT-PCR, respectively.
(C) Inhibition of IL-1b release by peritoneal macrophage from each CLR-deficient mouse model (black bar, /) and its appropriate WT counterpart (gray bar),
pretreated with Z-VAD-FMK (Zvad) and challenged with L.i., and quantified by ELISA. Results are expressed as the percentage of inhibition of IL-1b secretion
relative to the corresponding untreated control but challenged with L.i.
(D) Immunoblot blot analysis of caspase-1 p20 fragment cleavage in peritoneal macrophages from each CLR-deficient mousemodel (/) and its corresponding
WT counterpart (+/+) challenged with L.i. (+L.i.). ‘‘C’’ indicates uninfected control sample. Band intensity was quantified with Image J software and was
represented as the ratio between the band intensities of p20 and of b-actin.
(E) Inhibition of IL-1b release by peritoneal macrophages from each CLR-deficient mouse model (black bar, /) and its corresponding WT counterpart (gray
bar, +/+), pretreated with either Latrunculin A, Bay, or N-acetyl-cysteine, and then challenged with L.i. and quantified by ELISA. Results are expressed as the
percentage of IL-1b secretion inhibition relative to the corresponding untreated control but challenged with L.i.
(F) LTB4 production by peritoneal macrophages from each CLR-deficient mouse model (black bar, /) and its corresponding WT counterpart (gray bar, +/+),
then challenged with L.i. and quantified by enzyme immunoassay (EIA). See also Figure S3.
(G) qRT-PCR analysis of Lta4h, Alox5, and Alox15 mRNA levels in peritoneal macrophages from each CLR-deficient mouse model (black bar, /) and its
corresponding WT counterpart (gray bar, +/+) in response to L.i. challenge. The mRNA levels were represented in fold induction relative to the mRNA level
observed for the corresponding WT sample infected with L.i.
(legend continued on next page)
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Figure 5. Dectin-1, MR, and DC-SIGN
Contribute to the Modulation of Parasite
Proliferation in Human Monocyte-Derived
Macrophages
(A) CLR silencing in human macrophages. Genes
encoding for the indicated CLRs were silenced with
the lipid-based forward transfection of specific
SMARTpools (target) and nontargeting (control)
siRNAs in adherent MDMs, as described in the
Experimental Procedures section. Silencing was
then confirmed by flow cytometry analysis. Data
were displayed as the median of fluorescence dif-
ference. *p < 0.05, **p < 0.003 of siRNA target
compared to siRNA control.
(B–D) Luciferase activity indicating proliferation (B)
and ROS production (C), or IL-1b release (D), in
MDMs transfected with siRNAs targeting either each
of the indicated genes or nontargeting (control), and
challenged with L.i. (black) or not (white).
(E) LTB4 production by MDMs transfected with
the indicated siRNAs, challenged with L.i., and
quantified by EIA.
(F) IL-1b release in MDMs transfected simulta-
neously with the indicated siRNAs, challenged with
L.i., and quantified by ELISA.
Data are shown asmean ± SEM of triplicates and are
representative of three independent experiments.
*p < 0.05, **p < 0.001 compared to siRNA control
(B, D–F) or *p < 0.05, **p < 0.001 of infected cells
(black) compared to that noninfected (white) (C) and
#p < 0.05 compared to siRNA CD209 (F). See also
Figure S4 and Tables S1 and S2.
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Wenzel and Van Zandbergen, 2009). Even though LXA4 synthe-
sis requires ALOX5 and 12/15-lipoxygenase (ALOX15) activity
(Serhan, 2005) and Alox15 mRNA was diminished in SIGNR3-
deficient macrophages upon L.i. challenge (Figure 4G), the
LXA4 secretion was unchanged (Figure S3B). By contrast, MR-
deficient macrophages displayed significantly higher release of
LXA4, perhaps mediated by the augmented expression of
Alox15 mRNA (Figures 4G and S3B).
Taking these observations into account, we hypothesized that
signals downstream of SIGNR3 regulate caspase-1-dependent
production of IL-1b by altering the amount of ALOX5-derived
LTB4 during the macrophage response to L.i. To examine this,
we inhibited leukotriene synthesis through pharmacological
inactivation of 5-lipoxygenase-activating protein (FLAP) to deter-
minewhether elevated IL-1b secretion characteristic of activated
SIGNR3-deficient macrophages was affected. As predicted, the
FLAP inhibitor MK886 significantly reduced IL-1b secretion back
tobasal level for thesemacrophages infectedwithL.i. (Figure 4H).(H) IL-1b release by peritoneal macrophages fromCd209d-deficient mice (black bar,/) and its correspon
with the FLAP inhibitor MK886, in the presence or absence of LTB4 cotreatment, challenged with L.i., and
Data are shown as mean ± SEM of triplicates and are representative of at least three independent experime
and #p < 0.05, ##p < 0.001 compared to untreated CLR-deficient mice (A–C, E) or compared to CLR-defic
Immunity 38, 1038–1As a proof of principle, the addition of exog-
enous LTB4 restores the atypical high
amount of IL-1b secretion in the presenceof MK886, suggesting that control of LTB4 is crucial to the anti-
inflammatory effect triggered by signals downstream of SIGNR3
during the macrophage response to L.i. (Figure 4H). Collectively,
not only did we demonstrate the importance of MR in controlling
the synthesis of eicosanoidmediators in favor of themacrophage
microbicidal response against L.i., but we also found evidence
for a role for SIGNR3 in inhibiting this process, and therefore,
the caspase-1-induced production of IL-1b, shedding light to a
novel microbial strategy to enhance fitness in the host.
CLRs Modulate Parasite Proliferation in Human
Monocyte-Derived Macrophages
To analyze our findings from the murine model in a human
context, we optimized a lipid-based siRNA-mediated gene-
silencing protocol to inactivate the expression of CLEC7A
(encoding human Dectin-1), MRC1 (encoding human MR), and
CD209 (encoding humanDC-SIGN), in humanmonocyte-derived
macrophages (MDMs) (Figure 5A, Table S1). Similar to findings in
the murine model, cells became permissive to L.i. growth afterdingWT counterpart (gray bar, +/+), pretreated or not
then measured by ELISA.
nts. *p < 0.05, **p < 0.001 compared to untreated WT
ient mice treated only with MK886 (H).
049, May 23, 2013 ª2013 Elsevier Inc. 1045
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deficient for DC-SIGN became resistant to L.i. to proliferation
(Figure 5B). Although the induction of ROS production and
IL-1b secretion upon L.i. challenge was inhibited in MDMs
silenced for Dectin-1 or MR, cell lacking DC-SIGN had unaltered
or significantly increased amounts of ROS production and IL-1b
secretion, respectively (Figures 5C and 5D). Moreover, LTB4
production upon L.i. challenge was decreased inMDMs silenced
for MR but significantly increased in cells deficient for DC-SIGN
(Figure 5E). Finally, the simultaneous gene silencing for LTA4H
and DC-SIGN in MDMs (Figure S4) resulted in the significant
reduction of IL-1b secretion upon L.i. challenge, demonstrating
that, similar to SIGNR3, the downstream signals from DC-SIGN
influence the production and release of IL-1b via the control of
LTA4H expression, ultimately favoring parasite resilience in
human MDMs (Figure 5F). Altogether these data confirmed that
human homologs for each CLR display similar contributions to
the Leishmania-macrophage interaction, further supporting our
results obtained in the mouse model.
DISCUSSION
Macrophage polarization is an emerging concept to consider in
the Leishmania-macrophage interaction, because it plays an
essential role in immunity to, and pathogenesis of, multiple
microbes (Benoit et al., 2008). Ho¨lscher et al. (2006) demon-
strated that M2a macrophages are partly responsible for
BALB/c mice susceptibility to cutaneous Leishmania and that
impairment of this alternative program results in a delay of
disease progression, suggesting that this parasite has evolved
evasion mechanisms to thrive in these macrophages. For
these reasons, we assessed the contribution of functional and
phenotypical responses of macrophages during challenge with
Leishmania, in order to search for factors that influence disease
outcome in the context of macrophage polarization. Taken
together we believe that this study makes four major contribu-
tions to the field of host-pathogen interactions.
The first is that macrophages undergo anM2b-like program of
polarization upon L.i. challenge, identified by expression of
proinflammatory cytokines that differentiates the cells from other
M2 subsets; the simultaneous expression of IL-10, TGF-b1, and
other M2 biological markers separates the cells fromM1 macro-
phages; and the unique upregulation of CCL1 that distinguishes
them from all polarized macrophage states (Mantovani et al.,
2004). Furthermore, our in vivo results showed that macro-
phages from B6 mice infected by L.i. also present the marker
expression of the M2b program, alluding to the fact that this
phenotype is well sustained beyond the initial Leishmania-
macrophage interaction. The activation of the M2b-like program
upon L.i. challenge is intriguing given that these macrophages
are implicated in pathological contexts characterized by exces-
sive inflammation (Lefe`vre et al., 2010; Mantovani et al., 2004;
Zhang et al., 2010), and it also provides a biological context for
direct functional comparison between M2 subsets (Ho¨lscher
et al., 2006).
The second contribution of this study is the identification of the
CLR signature in M2b-like macrophages during L.i. infection and
the characterization of CLR divergent roles in the microbicidal
macrophage response. Among the M2 markers accentuated in1046 Immunity 38, 1038–1049, May 23, 2013 ª2013 Elsevier Inc.M2b-like macrophages upon L.i. challenge were Dectin-1, MR,
and SIGNR3. Because their roles were unknown either in L.i.
infection or in M2b macrophage biology, we dissected function
by using mouse models deficient for each CLR. Dectin-1 was
essential for the overall microbicidal response as shown by the
fact that Dectin-1-conditionally-deficient Clec7a/ mice were
unable to control L.i. infection. Moreover, in combination with
the silencing of human Dectin-1, which renders MDMs highly
permissive to this parasite’s growth, we showed both in murine
and human macrophages additional contributions for Dectin-1
in the production of proinflammatory factors in response to L.i.
We determined that mice deficient in a Syk-coupled CLR display
a systematic impairment in immunity to a nonfungal organism
(Osorio and Reis e Sousa, 2011). Similar to Dectin-1-con-
ditionally-deficient mice, MR-conditionally-deficient mice were
permissive to L.i. infection. This is a striking result given that
mice with a systematic deletion of MR display no impairment
of host responses to Leishmania or other pathogenic infection
(Akilov et al., 2007; Lee et al., 2003). One possible explanation
for this discrepancy is that MR expression in different cells
may play opposite biological roles that either become neutral-
ized upon systemic deletion or accentuated upon single cell-
targeted deletion, as demonstrated for the case of the MyD88
adaptor protein and its antagonistic roles between myeloid and
B cells (Neves et al., 2010). Nevertheless, the adoptive transfer
of WT macrophages ameliorated the susceptibility of MR-
conditionally-deficient mice, inferring that, similar to Dectin-1-
conditionally-deficient mice, the targeted disruption of these
CLRs inmacrophagesmight be the cause of the systemic vulner-
ability of L.i. infection. In line with these findings, we evidenced a
crucial role for MR in leishmanicidal activity in humans as well.
SIGNR3-deficient mice displayed no alteration in the immune
response to L.i. This was unexpected given that these mice are
susceptible to Mycobacterium tuberculosis during the early
stages of infection (Tanne et al., 2009). The lack of a phenotype
might be explained by the fact the systematic deletion of this
gene could prevent the formation of microenvironment and cell
liaisons during the development of the organism that might
otherwise be dependent later on the SIGNR3 expression for an
efficient immune response, as demonstrated for the expression
of SIGNR1 in macrophages and B cells, whose liaison is crucial
to the response against Streptococcus pneumoniae (Koppel
et al., 2008). Alternatively, the in vivo function of SIGNR3 during
the immune response to L.i. might be compensated by SIGNR1
and SIGNR5, which play a minor role against Mycobacterium
tuberculosis (Tanne et al., 2009). Nevertheless, we showed that
the Leishmania’s ability to thrive inside of murine and human
macrophages deficient for SIGNR3 was significantly diminished,
a subject for which we devote further discussion below.
The third contribution is the inference of Dectin-1-Syk-
p47phox and MR-AA-NADPH oxidase signaling pathways to
the respiratory burst during L.i. infection. Beyond the overall
negative effect observed in vitro for human and murine macro-
phages lacking Dectin-1 or MR, the identification of these
signaling pathways during the Leishmania-macrophage interac-
tion gives rise to a couple of aspects worth mentioning. The first
was the identification of the Syk-dependent ROS production via
a Dectin-1 receptor in L.i. infection, one of the few pathogenic
contexts aside from fungal infection (Osorio and Reis e Sousa,
Immunity
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oxidase signaling pathway. Although MR was one of the first
CLRs shown to bind different pathogens, there is limited
evidence to date that MR is sufficient to provoke microbicidal
effector functions in myeloid cells (Osorio and Reis e Sousa,
2011). Here, we provided evidence that MR promotes the
assembly of cytosolic phox subunits of NADPH oxidase to the
membrane through AA mobilization. Thus, reduced amounts of
AA might therefore explain the deficiency in ROS production
observed for MR-deficient murine and human macrophages.
Lastly, this study identifies the signaling pathways leading to
the activation or inhibition of IL-1b release during L.i. infection.
Indeed, the fact that L.i. challenge activates the caspase-1-
dependent IL-1b secretion in macrophages suggests the
involvement of the inflammasome activation as a general but
powerful antimicrobial strategy in innate immunity, as corrobo-
rated recently for fungal pathogens (Hise et al., 2009). We
identified both Dectin-1 and MR as extracellular sensors for
Leishmania PAMPs that activate pro-IL-1b processing via
caspase-1-dependent activity, a finding that is strongly sup-
ported by a recent study implicating Dectin-1 in the inflamma-
some complex activation by fungal pathogens (Cheng et al.,
2011). Beyond the prerequisite of Leishmania internalization for
the IL-1b response in macrophages, we also provided evidence
for additional requirement for Syk-coupled signaling. These
observations are not only consistent with the role of Syk in
both the activation of the pro-IL-1b synthesis and in the control
of its proteolytic processing (Gross et al., 2009; Osorio and
Reis e Sousa, 2011), but they also promote Syk-coupled CLRs
as important activators of antimicrobial response. Futhermore,
we provided evidence for the partial contribution of ROS produc-
tion to IL-1b secretion, an observation highlighting the potential
of L.i. to act on diverse signals (e.g., potassium efflux, ATP
release) and induce the inflammasome complex activation
(Martinon et al., 2009). Alternatively, Leishmania has evolved
strategies to circumvent the hostile environment provoked by
IL-1b (Shio et al., 2012). Here, we identified one involving
SIGNR3 (and the human homolog DC-SIGN) to downregulate
the expression of LTA4H, whose enzymatic activity is critical
for LTB4 synthesis, and consequently, for the caspase-1-depen-
dent activation of IL-1b. Considering that LTB4 was recently
shown to participate in the inflammasome activation (Amaral
et al., 2012) and known to have a significant role in the leishma-
nicidal mechanisms (Serezani et al., 2006), the identification of
SIGNR3 as an extracellular sensor for Leishmania’s control of
LTB4 synthesis represents a major breakthrough in the host-
pathogen interaction field for various reasons. First, it suggests
other CLRs might influence the production of eicosanoid media-
tors in response to Leishmania and perhaps other pathogens.
Indeed, we also provided evidence that MR upregulates LTB4
production, leading to IL-1b secretion.Moreover, the contrasting
modulation of LTB4 between MR and SIGNR3 points toward a
delicate balance in play between this proinflammatory factor
and the anti-inflammatory LXA4. This is best supported by the
L.i.-induced reciprocal expression patterns of the enzymes
responsible for their synthesis in MR- and SIGNR3-deficient
backgrounds and by the higher LXA4 release in L.i.-infected cells
lacking MR. In the context of host-pathogen interaction, we pre-
dict that an elevated LTB4/LXA4 ratio will benefit the host,whereas a low LTB4/LXA4 ratio will benefit the pathogen.
Second, the well-known manipulation of its human counterpart,
DC-SIGN, as a ‘‘Trojan Horse’’ strategy to subvert the host cells
might depend on the ability to control the inflammasome via the
modulation of leukotriene synthesis, independently from the
established modulation of NF-kB activity resulting in IL-10 over-
expression (van Kooyk and Geijtenbeek, 2003). Third, our find-
ings extend to other pathological chronic inflammation diseases
beyond host-pathogen interactions. Recently, an anti-inflamma-
tory role for DC-SIGNwas demonstrated in IVIG (high-dose intra-
venous immunoglobulin) therapy against autoimmunity (Anthony
et al., 2011). Our findings may further explain how DC-SIGN
prevents chronic inflammation through tight control of the
caspase-1-dependent inflammasome and may provide a new
theurapeutic venue toward broad modulation of leukotrien syn-
thesis via CLR signaling. One final implication points toward
the biological role of DC-SIGN during steady-state conditions.
It is possible that this CLR might be the ‘‘peace keeper’’ in
immuno-privileged sites, mucosal tissue constantly exposed to
environmental signals, and key sites with a high microbiota
content, where the tight control over the inflammasome complex
might allow DC-SIGN-expressing cells to perform housekeeping
functions. This has been shown recently for Dectin-1 in the
interaction with commensal fungi, a liaison that prevents colitis
in mice (Iliev et al., 2012).
In conclusion, we have shown that the Leishmania-macro-
phage interaction can be influenced by the state of macrophage
polarization at the cellular level and by members of the CLR
family at the molecular level. Our findings suggested that effec-
tivemodulation of these cellular andmolecular factorsmight shift
the Leishmania-macrophage interaction for the benefit of the
patient. Research in this area might provide breakthroughs in
terms of diagnoses, vaccine, and therapy for leishmaniasis.EXPERIMENTAL PROCEDURES
Mice
Mice were bred and handled under protocols approved by the Conseil
Scientifique du Centre de Formation et de Recherche Experimental Me´dico
Chirurgical and the ethics board of the Midi-Pyre´ne´es ethic committee for
animal experimentation (experimentation permit number 31-067, approval
number B3155503). C57BL/6 mice were purchased from Janvier. Clec7a/
and Cd209d/mice have been described earlier (Gale`s et al., 2010; Wethmar
et al., 2006). Mrc1/ mice are described in Supplemental Experimental
Procedures. For Clec7a/ andMrc1/mice, the corresponding floxed litter-
mates were used as controls throughout all the pertaining experiments.
For the in vivo experiments, a visceral infection was established by inocu-
lating i.p. 50 3 106 stationary phase promastigotes/mouse. At 14 days after
infection, blood samples were collected and the spleen and peritoneal macro-
phages were removed aseptically. The quantification of L.i. in tissues was
done by LightCycler PCR (Roche Diagnostics) as detailed in Supplemental
Experimental Procedures.
For adoptive transfers, peritoneal macrophages from three WT donor mice
were collected and transferred (i.p.) into the corresponding CLR-deficient
recipient mouse model (n = 6) 10 hr before L.i. infection. Blood samples and
spleens were isolated 14 days after infection for L.i. quantification.
Preparation of Human Monocyte-Derived Macrophages and siRNA
Gene Silencing
Monocytes were obtained from healthy blood donors (Etablissement Franc¸ais
de Sang, EFS). Written informed consents were obtained from the donors
under EFS contract number 21/PVNT/TOU/IPBS01/2009-0052. According toImmunity 38, 1038–1049, May 23, 2013 ª2013 Elsevier Inc. 1047
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Diverging Roles for CLRs in Leishmania Infectionarticles L1243-4 and R1243-61 of the French Public Health Code, the contract
was approved by the French Ministry of Science and Technology (agreement
number AC 2009-921). Monocytes were differentiated into MDMs as previ-
ously described (Tailleux et al., 2003) and used to perform lipid-based
siRNA-mediated gene silencing as detailed in Supplemental Experimental
Procedures.
Proliferation, Phagocytosis, Binding Assays, ROS Production, ELISA
Cytokine Titration, and EIA Lipid Quantification
Adherent murine peritoneal macrophages were prepared as previously
described (Lefe`vre et al., 2010) and pretreated 30 min before L.i. challenge
with Bay 61-3606 (Bay) (Sigma, 10 mM), MAFP (Sigma, 10 mM), Z-VAD-FMK
(Z-vad) (50 mM, Calbiochem), Latrunculin A (0.5 mg/ml, Invitrogen), N-Acetyl-
Cysteine (10 mM, Sigma), MK886 (10 mM, Sigma), or LTB4 (107 M,
Cayman). For all the in vitro experiments, the parasite-to-macrophage ratio
used was 5:1.
To evaluate the binding, phagocytosis, and proliferation of L.i., the macro-
phages were challenged with L.i.-luc for 30 min at 4C (binding) or 37C
(phagocytosis) and for 48 hr at 37C (proliferation). The luciferase activity
was measured with a luminometer (Wallac). The ROS production in response
to L.i.wasmonitored for 1 hr, as described previously (Lefe`vre et al., 2010). The
cytokine and chemokine releases of macrophages challenged with L.i. for 6 hr
were evaluated by ELISA (OptiEIA and BD Biosciences kits for IL-1b, IL-6,
TNF-a, IL-10; R&D System for TGF-b1, CCL1, and CCL17). The LTB4 and
LXA4 production by macrophages stimulated with L.i. for 3 hr were quantified
by EIA as recommended by the manufacturer’s protocol (LTB4 and LXA4 EIA
kit, Oxford).
Reverse Transcription and Real-Time PCR
Adherent murine macrophages were stimulated with L.i. for 4 hr. The mRNA
preparation and the synthesis of cDNA were performed according to the
manufacturer’s recommendations (RNeasy Mini Kit columns, QIAGEN;
Thermo Electron). qRT-PCR was performed on a LightCycler 480 system
with LightCycler SYBR Green I Master (Roche Diagnostics). The primers are
listed in Table S2. Actin mRNA was used as the invariant control. Serially
diluted samples of pooled cDNA were used as external standards in each
run for the quantification and results were expressed in fold induction relative
to the respective control.
Immunoblot Analysis
For phospho-p47phox analysis, themacrophageswere pretreated 30minwith
Bay before L.i. stimulation (3 hr). For Caspase-1 p20 fragment cleavage anal-
ysis, the macrophages were stimulated with L.i. for 6 hr. Total protein lysates
were extracted according to standard procedures. After protein transfer,
membranes were incubated with either a rabbit polyclonal anti-phospho
p47phox (Sydlabs), a goat polyclonal anti-p47phox (Santa Cruz), or a rabbit
anti-Caspase-1 antibody (Clinisciences). Proteins were visualized with the
ECL kit (Amersham Pharmacia Biotech). Band intensity was quantified with
Image J software.
Flow Cytometry
For human MDMs staining, we used the following antibodies: anti-CLEC7A
(Dectin-1) (R&D Systems), anti-MRC1 (MR), and anti-CD209 (DC-SIGN) (BD
Biosciences). The FACS analyses were done in a Becton Dickinson LSRII
flow cytometer with the FlowJo software.
For mouse macrophages, after 10 hr of stimulation with L.i., the cells were
labeled with the following antibodies: anti-Clec7a and anti-Fcgr3/Fcgr2b
(CD16/32; Serotec), anti-Cd209d (SIGNR3; 4A4) provided by K. Takahara,
anti-Cd36 (Santa Cruz), and anti-Chi3l3 (YM1; R&D Systems). To evaluate
the MR surface expression, we used MR-specific ligand conjugated with
FITC (Sigma). The FACS analyses were done in a Becton Dickinson
FACScalibur flow cytometer with CellQuestPro software.
Arachidonic Acid Mobilization
Murine peritoneal macrophages were prelabeled with [3H]arachidonic acid
(1 mCi/ml). The prelabeled macrophages were pretreated with 10 mM of
MAFP, a specific inhibitor of cPLA2 for 20 min, and then infected with L.i. for
2 hr. The [3H]arachidonic acid metabolites released into the culture medium1048 Immunity 38, 1038–1049, May 23, 2013 ª2013 Elsevier Inc.by macrophages were quantified by measurement of the radioactivity by
beta liquid scintillation counting with a 1217 Wallac Rackbeta LKB 1217.
Statistical Analysis
For each experiment, the data were subjected to one-way analysis of variance
followed by the means multiple comparison method of Bonferroni-Dunnett.
For the evaluation of the number of mice positive for L.i. in the blood, the
statistical c2 test was used. p < 0.05 was considered as the level of statistical
significance.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2013.04.010.
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